Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Martha, Gonzalez"'
Autor:
Debra Perrone, Melissa M. Rohde, Courtney Hammond Wagner, Rebecca Anderson, Samantha Arthur, Ngodoo Atume, Meagan Brown, Lauren Esaki-Kua, Martha Gonzalez Fernandez, Kelly A. Garvey, Katherine Heidel, William D. Jones, Sara Khosrowshahi Asl, Carrie Munill, Rebecca Nelson, J. Pablo Ortiz-Partida, E. J. Remson
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-14 (2023)
Abstract Natural resources policies that promote sustainable management are critical for protecting diverse stakeholders against depletion. Although integrating diverse stakeholders into these policies has been theorized to improve protection, empiri
Externí odkaz:
https://doaj.org/article/0af55a0a649c426fa1523f3b525755e1
Autor:
Martha Gonzalez
As the lead singer of the Grammy Award–winning rock band Quetzal and a scholar of Chicana/o and Latina/o studies, Martha Gonzalez is uniquely positioned to articulate the ways in which creative expression can serve the dual roles of political comme
Publikováno v:
Indian Journal of Ophthalmology, Vol 71, Iss 6, Pp 2399-2408 (2023)
Painful-blind eye (PBE) is a challenging and debilitating condition that greatly affects the quality of life of patients. Although PBE can result from a variety of etiologies, currently there is no guideline or consensus on how to approach therapeuti
Externí odkaz:
https://doaj.org/article/4d2bc9e71a2f4081847139ab7b614747
Autor:
Leena Penumalee, Jennifer O'Neil Lambert, Martha Gonzalez, Melanie Gray, Ekta Partani, Celia Wilson, Rebecca Etz, Bergen Nelson
Publikováno v:
Academic Pediatrics. 23:329-335
Despite strong evidence that social factors have a large influence on child health, systematic screening for social needs is not performed universally in pediatric primary care. This is due to multiple barriers, including concerns about acceptability
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2040c69bbd2569916ec474929ab5939
https://doi.org/10.1016/j.acap.2022.07.002
https://doi.org/10.1016/j.acap.2022.07.002
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Martha Gonzalez
Publikováno v:
Journal of American Folklore. 136:114-116
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67305b41572e85296215f00809548c39
https://doi.org/10.5406/15351882.136.539.13
https://doi.org/10.5406/15351882.136.539.13
Autor:
Josep Tabernero, Jeffrey Infante, Hong Xie, Trilok Parekh, Italo Poggesi, Ademi Santiago-Walker, Bob Zhong, Martha Gonzalez, Alexander Spira, Ramaswamy Govindan, Victor Moreno, Emiliano Calvo, Mark Awad, Nancy Chan, Andres Cervantes, Alain Mita, Cinta Hierro, Antoine Italiano, Rastislav Bahleda
Supplementary Figure S1. Mean concentration-time erdafitinib profiles after a single dose (cycle 1 day 1 [C1D1]) and at steady-state (cycle 2 day 1 [C2D1]) after daily dosing (Panel A) or intermittent dosing (Panel B). 9 mg QD Part 1 at Cycle 2 Day 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00acc2d3f00797dbaef39a6ed0dbfe43
https://doi.org/10.1158/1078-0432.22473305
https://doi.org/10.1158/1078-0432.22473305
Autor:
Josep Tabernero, Jeffrey Infante, Hong Xie, Trilok Parekh, Italo Poggesi, Ademi Santiago-Walker, Bob Zhong, Martha Gonzalez, Alexander Spira, Ramaswamy Govindan, Victor Moreno, Emiliano Calvo, Mark Awad, Nancy Chan, Andres Cervantes, Alain Mita, Cinta Hierro, Antoine Italiano, Rastislav Bahleda
Purpose:Here, we report results of the first phase I study of erdafitinib, a potent, oral pan-FGFR inhibitor.Patients and Methods:Patients age ≥18 years with advanced solid tumors for which standard antineoplastic therapy was no longer effective we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b2f25bf34cec3cbf26bf3cd93cabcbe
https://doi.org/10.1158/1078-0432.c.6528470
https://doi.org/10.1158/1078-0432.c.6528470
Autor:
Josep Tabernero, Jeffrey Infante, Hong Xie, Trilok Parekh, Italo Poggesi, Ademi Santiago-Walker, Bob Zhong, Martha Gonzalez, Alexander Spira, Ramaswamy Govindan, Victor Moreno, Emiliano Calvo, Mark Awad, Nancy Chan, Andres Cervantes, Alain Mita, Cinta Hierro, Antoine Italiano, Rastislav Bahleda
Supplementary Table S1. Arithmetic Mean {plus minus} SD Plasma Erdafitinib Pharmacokinetic Parameters after the First Erdafitinib Administration (Cycle 1 Day 1) or at Steady-State (Cycle 2 Day 1) in Patients Assigned to the Continuous Daily Dosing or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::181ba3148e5e41e416d99bcb7190db0d
https://doi.org/10.1158/1078-0432.22473296
https://doi.org/10.1158/1078-0432.22473296
Publikováno v:
In Procedia - Social and Behavioral Sciences 12 February 2015 174:768-775